This week, three publications in the healthcare policy and regulatory affairs industries referenced MGA’s recent report on the potential savings from accelerating US approval of complex generics.
MGA founder and CEO Alex Brill recently appeared on The Hill event Virtually Live to discuss how complex generic medical alternatives can impact and potentially enhance the American healthcare system. In this interview, Brill talks with The Hill moderator Steve Clemons about the MGA report outlining the potential savings from accelerating US approval of complex generics.
Matrix Global Advisors (MGA) today released a new report, “Potential Savings from Accelerating US Approval of Complex Generics,” by MGA founder and CEO Alex Brill.
